Syndax Pharmaceuticals, Inc. (SNDX) vs Taysha Gene Therapies, Inc. (TSHA)
Syndax Pharmaceuticals, Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Syndax Pharmaceuticals, Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.6B and $1.6B). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 222.3% against 19.0%. Taysha Gene Therapies, Inc. has the higher net margin (0.00% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 17 metrics below, Taysha Gene Therapies, Inc. leads on 11 and Syndax Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | SNDX | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.78% | 100.00% | 65.16% |
| Operating margin | (77.05%) | 0.00% | 0.00% |
| Net margin | (87.60%) | 0.00% | 0.00% |
| Free cash flow margin | (87.64%) | 0.00% | 0.00% |
| Return on equity | (255.93%) | (47.05%) | (57.72%) |
| Return on assets | (33.97%) | (37.23%) | (49.22%) |
| Return on invested capital | (247.93%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack